Children's National Health System
Washington D.C., District of Columbia, 20010, United States
Location status: Recruiting
NCT Number: NCT03794362
It is generally recognized that pain assessment and management especially in newborns, children and other nonverbal populations is an unmet need. According to the American Medical Association, "the pediatric population is at risk of inadequate pain management, with age-related factors affecting pain management in children. Children are often given minimal or no analgesia for procedures that would routinely be treated aggressively in adults. Although much is now known about pain management in children, it has not been widely or effectively translated into routine clinical practice". These two factors combine to emphasize the necessity for an objective tool to quantify pain and monitor the effectiveness of analgesia, especially during treatments. Further, it is reported that many patients require a combination of treatments, and it is often necessary to test a variety of treatments before the personal match for treatment is found. The method in place to change the care on a subjective basis is difficult, time consuming, and not easily individualized. This pilot study is part of an ongoing effort to develop a method to objectively assess response to specific analgesic interventions. It specifically aims to discern the impact of analgesic interventions on sensory nerve fiber sensitivity in a diverse patient population.
Interested in participating?
Request Info7 year–21 year
All sexes
Observational
Washington D.C., District of Columbia, 20010, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 0, 15, 30, 45, 60, 90, 120, 180 minutes
The changes that occur in PRD AUC as a response to an analgesic intervention will be investigated. The differences are calculated by comparing the parameters from before the intervention to after the intervention.
Time frame: 0, 15, 30, 45, 60, 90, 120, 180 minutes
The changes that occur in PLR Latency as a response to an analgesic intervention will be investigated. The differences are calculated by comparing the parameters from before the intervention to after the intervention.
Time frame: 0, 15, 30, 45, 60, 90, 120, 180 minutes
The changes that occur in PLR Amplitude as a response to an analgesic intervention will be investigated. The differences are calculated by comparing the parameters from before the intervention to after the intervention.
Time frame: 0, 15, 30, 45, 60, 90, 120, 180 minutes
The changes that occur in PLR Recovery Time as a response to an analgesic intervention will be investigated. The differences are calculated by comparing the parameters from before the intervention to after the intervention.
Time frame: 0, 15, 30, 45, 60, 90, 120, 180 minutes
The changes that occur in PRD amplitude as a response to an analgesic intervention will be investigated. The differences are calculated by comparing the parameters from before the intervention to after the intervention.
Contact information is provided by the study sponsor or research team.
Julia Finkel
Other
Developing a Method to Objectively Measure Analgesic Interventions: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05563792
Agnosia, Chronic Pain
Indianapolis, Indiana, United States
View Trial DetailsNCT07226700
Agnosia, JOURNAVX
New York, United States
View Trial DetailsNCT07562412
Acute Pain, Agnosia
Tallahassee, Florida, United States
View Trial DetailsNCT06498713
Agnosia, Nervous System Diseases
New Haven, Connecticut, United States
View Trial Details